Connor Clark & Lunn Investment Management Ltd. Reduces Stock Position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Connor Clark & Lunn Investment Management Ltd. lowered its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,016 shares of the biopharmaceutical company’s stock after selling […]
Connor Clark & Lunn Investment Management Ltd. lowered its stake in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,016 shares of the biopharmaceutical company’s stock after selling […]
